Exponent, Inc. (NASDAQ:EXPO) Director Sells $123,539.00 in Stock

Exponent, Inc. (NASDAQ:EXPO) Director Paul R. Johnston sold 1,300 shares of Exponent stock in a transaction that occurred on Wednesday, November 20th. The shares were sold at an average price of $95.03, for a total transaction of $123,539.00. Following the completion of the sale, the director now owns 59,406 shares of the company’s stock, valued at $5,645,352.18. This trade represents a 2.14 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink.

Exponent Stock Up 2.3 %

NASDAQ EXPO opened at $98.04 on Friday. The stock has a market capitalization of $4.98 billion, a PE ratio of 47.36 and a beta of 0.69. The company has a 50 day moving average price of $106.31 and a two-hundred day moving average price of $102.07. Exponent, Inc. has a 12-month low of $68.70 and a 12-month high of $115.75.

Exponent Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Friday, December 20th. Shareholders of record on Friday, December 6th will be paid a $0.28 dividend. This represents a $1.12 dividend on an annualized basis and a yield of 1.14%. The ex-dividend date is Friday, December 6th. Exponent’s dividend payout ratio (DPR) is presently 54.11%.

Hedge Funds Weigh In On Exponent

A number of institutional investors have recently modified their holdings of the company. Anchor Investment Management LLC bought a new position in shares of Exponent in the third quarter valued at approximately $64,000. Westside Investment Management Inc. bought a new position in shares of Exponent in the third quarter valued at approximately $26,000. Coldstream Capital Management Inc. bought a new position in shares of Exponent in the third quarter valued at approximately $556,000. Geode Capital Management LLC raised its position in shares of Exponent by 4.8% in the third quarter. Geode Capital Management LLC now owns 1,505,652 shares of the business services provider’s stock valued at $173,597,000 after purchasing an additional 69,099 shares during the period. Finally, Barclays PLC increased its position in Exponent by 219.0% during the third quarter. Barclays PLC now owns 96,526 shares of the business services provider’s stock worth $11,127,000 after acquiring an additional 66,263 shares during the period. Institutional investors own 92.37% of the company’s stock.

Analyst Ratings Changes

Separately, Truist Financial reiterated a “buy” rating and issued a $120.00 target price (up from $100.00) on shares of Exponent in a research note on Friday, July 26th.

Exponent Company Profile

Exponent, Inc, together with its subsidiaries, operates as a science and engineering consulting company in the United States and internationally. The company operates in two segments, Engineering and Other Scientific, and Environmental and Health. The Engineering and Other Scientific segment provides services in the areas of biomechanics, biomedical engineering and sciences, buildings and structures, civil engineering, construction consulting, data sciences, electrical engineering and computer science, human factors, materials and corrosion engineering, mechanical engineering, polymer science and materials chemistry, thermal sciences, and vehicle engineering.